期刊文献+

国产唑来膦酸治疗恶性肿瘤骨转移24例临床观察 被引量:6

Clinical observation of zoledronic acid in the treatment of bone metastatic cancer
下载PDF
导出
摘要 目的观察国产唑来膦酸(博来宁)治疗恶性肿瘤骨转移的临床疗效和不良反应。方法国产唑来膦酸4mg加入0.9%氯化钠溶液100ml中静脉滴注15分钟。每4周重复给药1次,3次后评价疗效。结果止痛有效率为79.2%,维持中位时间25天。活动能力改善有效率为66.7%。结论国产唑来膦酸可缓解恶性肿瘤骨转移所致疼痛,改善生活质量,且不良反应轻微,耐受性好。 Objective:To evaluate clinical efficacy and toxicity of zoledronic acid in the treatment of the bone metastases in patients with malignancy. Methods: Twenty four patients with bone metastatic cancer were treated with zoledronic acid 4mg by intravenous infusion for 15 minutes. The treatment was repeated every 28 days, up to 3 times. Results :The response rate of bone pain relief was 79.2%. The median maintain time was 25 days. The response rate of activity improvement was 66.7%. Conclusion: Zoledronic acid can relieve bone pain and improve quality of life in patients with metastatic cancer of bone. The toxicity was mild and well tolerated.
出处 《现代肿瘤医学》 CAS 2006年第7期889-890,共2页 Journal of Modern Oncology
关键词 唑来膦酸 骨转移癌 疼痛 zoledronic acid bone metastatic cancer pain
  • 相关文献

参考文献9

二级参考文献11

  • 1秦叔逵,陈映霞,马永泉,李锡麟,刘璐,吴复平.骨膦和^153Sm—EDTMP治疗骨转移癌[J].肿瘤防治研究,1995,22(1):25-27. 被引量:22
  • 2[2]Coleman RE,Purohit OP.Osteoclast inhibition for the treatment of bone metastases.Cancer Treat Rev,1993,19(2):79~203
  • 3[4]Lipton A, Samll E, Saad F, et al. The new bisphonate, Zometa (zoledronci acid) decreases skeletal complications in both lytic and blastic lestic lesions: a comparision to pamidronate. Cancer Invest 2001,20(1):45~47
  • 4[5]Lipton A, Costa L, Ali S, et al. Use of bone turnover for monitoring bone metastases and response to therapy. Semminars in Oncology, 2001, 28(4): 254~259
  • 5[6]Ralston SH, Patel U, Fraser WD, et al. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcemia. Lancet , 1989,20(2):180~182
  • 6Green JR, Muller K, Jaeggi K A. Preclinical pharmacology of CGP2446 a new , potent, hrterocyclic bisphosphonate compound[J].J Bone Miner Res, 1994,9(5):745~751.
  • 7Pecherstorfer M, Ludwig H, Schlosser K, et al. Administration of the bisphosphonate ibandronate(BM 21.0955) by intravenous bolus injection [J].J Bone Miner Res, 1996,14(5):587~593.
  • 8金懋林,杨伯琴,雷兰英,高禹.帕米膦酸钠治疗骨转移引起疼痛的疗效观察[J].中华肿瘤杂志,1998,20(4):310-312. 被引量:46
  • 9代志军,王西京,刘小旭,康华峰,薛峰杰,薛兴欢.艾本治疗骨转移癌疼痛的临床疗效[J].陕西肿瘤医学,2003,11(1):36-37. 被引量:5
  • 10王成,张彩霞,王立波.艾本治疗骨转移癌引起疼痛的临床观察[J].实用肿瘤学杂志,2003,17(2):129-131. 被引量:5

共引文献75

同被引文献33

  • 1李钧,张楠,孔凡英,孙玉萍.唑来膦酸治疗恶性肿瘤骨转移研究进展[J].癌症进展,2005,3(5):486-489. 被引量:11
  • 2姚元虎,章龙珍,杜秀平,唐天友,韩正祥,王建设.放射治疗联合唑来膦酸治疗骨转移癌疗效观察[J].现代肿瘤医学,2006,14(12):1595-1597. 被引量:5
  • 3Sad F, Gleson DM, murray R, et al. A randomized, placebocontrolled trial of zoledronic acid in patients with hormone-re-fractory metastatic prostate carcinoma [ J ]. J Natl cancer Inst, 2002,94 ( 19 ) : 1458- 1468.
  • 4Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors a phase Ⅲ, double blind randomized, trial-the zuledronic Acid Lung Cancer and Other Solid Tumors study Group[ J]. J clin Oncol,2003,21 (16) :3150-3157.
  • 5谷铣之.肿瘤放射治疗学[M].2版.北京:北京医科大学中国协和医科大学联合出版社,1994:817.
  • 6Rodam GA, F|eisch HA. Bisphosphonates: mechanisms of action [J]. J Clin Invest,1996,97(12) :2692-2696.
  • 7Evdokilu A, labrinidis A. Induction of ceel death of human Osteogenic sarcoma cells by zoledronie acid resembles anoikis [ J ]. Bone, 2003,33(2) :216.
  • 8Neville-webbe H, Coleman RE. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia [ J ]. Palliat Med,2003.17(6) :539.
  • 9张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 10谷铣之 殷蔚伯.肿瘤放射治疗学[M].北京:北京医科大学协和医科大学联合出版社,1994.232-236.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部